S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
C$0.70
+6.1%
C$0.67
C$0.55
C$2.37
C$152.45M0.5205,577 shs209,563 shs
Colabor Group Inc. stock logo
GCL
Colabor Group
C$1.21
+0.8%
C$1.20
C$0.72
C$1.33
C$123.41M0.76101,302 shs98,605 shs
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
C$30.80
-3.3%
C$30.80
C$14.01
C$36.02
C$10.76BN/A1.38 million shs1.23 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
+6.06%+2.94%+9.37%-4.11%-67.44%
Colabor Group Inc. stock logo
GCL
Colabor Group
+0.83%+3.42%+4.31%+3.42%+61.33%
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
0.6172 of 5 stars
3.50.00.80.00.00.00.0
Colabor Group Inc. stock logo
GCL
Colabor Group
N/AN/AN/AN/AN/AN/AN/AN/A
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
3.00
BuyC$3.93461.90% Upside
Colabor Group Inc. stock logo
GCL
Colabor Group
N/AN/AN/AN/A
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
N/AN/AC$0.05 per share13.31C$0.33 per shareN/A
Colabor Group Inc. stock logo
GCL
Colabor Group
C$659.13M0.19C$0.04 per share29.60C$1.06 per share1.14
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
-C$3.92M-C$0.02N/AN/AN/A-5.84%-6.31%4/26/2024 (Estimated)
Colabor Group Inc. stock logo
GCL
Colabor Group
C$6.05MC$0.0620.170.610.85%5.72%3.50%5/1/2024 (Estimated)
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
N/AN/AN/AN/AN/A
Colabor Group Inc. stock logo
GCL
Colabor Group
C$0.2419.83%N/A400.00%N/A
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
0.32
18.49
11.23
Colabor Group Inc. stock logo
GCL
Colabor Group
158.98
1.74
0.76
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
4.49%
Colabor Group Inc. stock logo
GCL
Colabor Group
12.04%
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
N/A217.78 millionN/ANot Optionable
Colabor Group Inc. stock logo
GCL
Colabor Group
729101.99 millionN/ANot Optionable
Valeant Pharmaceuticals International, Inc. stock logo
VRX
Valeant Pharmaceuticals International
N/A349.30 millionN/ANot Optionable

VRX, GCL, LPD, CRE, and MEU Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Critical Elements Lithium logo

Critical Elements Lithium

CVE:CRE
Critical Elements Lithium Corporation engages in the acquisition, exploration, and development of mining properties in Canada. The company explores for copper, zinc, gold, silver, nickel, lead, lithium, niobium, tantalum, platinum group, and rare earth elements. Its flagship project is the Rose Lithium-Tantalum project that consists of 473 claims covering a total area of 244.99 square kilometers located in the Eastmain greenstone belt. The company was formerly known as Critical Elements Corporation and changed its name to Critical Elements Lithium Corporation in June 2019. Critical Elements Lithium Corporation was incorporated in 2006 and is headquartered in Blainville, Canada.
Colabor Group logo

Colabor Group

TSE:GCL
Colabor Group Inc., together with its subsidiaries, markets and distributes food and food-related products in Canada. It operates in two segments, Distribution and Wholesale. The Distribution segment offers frozen products, dry staples, dairy products, meat, seafood, fruits and vegetables, disposables, and sanitation products, as well as fish products. This segment serves restaurants, hotels, foodservice operators, specialty food stores, healthcare institutions, schools and universities, and other retail customers. The Wholesale segment provides food, food-related, and non-food products to distributors, food service, and retail industries. Colabor Group Inc. was founded in 1962 and is headquartered in Quebec, Canada.
Valeant Pharmaceuticals International logo

Valeant Pharmaceuticals International

TSE:VRX
Valeant Pharmaceuticals International, Inc. operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment provides pharmaceutical products, OTC products, and medical device products, primarily consist of Bausch + Lomb products, with a focus on the vision care, surgical, consumer, and ophthalmology Rx products in the United States; and pharmaceutical products, generic pharmaceutical products, OTC products, medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia and New Zealand, Latin America, Africa, and the Middle East. The Branded Rx segment sells gastrointestinal and dermatological products in the United States. The U.S. Diversified Products segment offers pharmaceutical products, OTC products, and medical device products in the areas of neurology and certain other therapeutic classes, including aesthetics. The company was founded in 1983 and is headquartered in Laval, Canada.